IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type i interferons-dependent and-independent anticancer activity

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Kumar, S ^a   Ingle, H ^a   Mishra, S ^a   Mahla, R S ^a   Kumar, A ^a   Kawai, T ^b   Akira, S ^c   Takaoka, A ^d   Raut, A A ^e   Kumar, H ^a,c  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e ICAR National Institute of High Security Animal Diseases   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERFERON; INTERFERON BETA PROMOTER STIMULATOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; ONCOLYTIC VIRUS; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; BCL2 PROTEIN, HUMAN; BIRC3 PROTEIN, HUMAN; CANCER VACCINE; INHIBITOR OF APOPTOSIS PROTEIN; IRF3 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; PRKCE PROTEIN, HUMAN; PROTEIN BCL 2; PROTEIN KINASE C EPSILON; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UBIQUITIN PROTEIN LIGASE; VISA PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BCL2 GENE; BIRC3 GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NEWCASTLE DISEASE VIRUS; NONHUMAN; PRIORITY JOURNAL; PRKCE GENE; PROTEIN EXPRESSION; TRAL GENE; UPREGULATION; BIOSYNTHESIS; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; NEOPLASM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CANCER VACCINES; CELL LINE, TUMOR; DOWN-REGULATION; HEK293 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; NEOPLASM INVASIVENESS; NEOPLASMS; NEWCASTLE DISEASE VIRUS; POLY I-C; PROTEIN KINASE C-EPSILON; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84970925335     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.122     Document Type: Article

References (40)

1. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6: 981-988.
2. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437: 1167-1172.
3. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122: 669-682.
4. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005; 19: 727-740.
5. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006; 203: 1795-1803.
6. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT. Anti-apoptosis and cell survival: a review. Biochim Biophys Acta 2011; 1813: 238-259.
7. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004; 4: 11-22.
8. Lee S, Margolin K. Cytokines in cancer immunotherapy. Cancers 2011; 3: 3856-3893.
9. Duewell P, Steger A, Lohr H, Bourhis H, Hoelz H, Kirchleitner SV et al. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Cell Death Differ 2014; 21: 1825-1837.
10. Cheng YS, Xu F. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther 2010; 10: 1219-1223.
11. Wagner TC, Velichko S, Chesney SK, Biroc S, Harde D, Vogel D et al. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors. Int J Cancer 2004; 111: 32-42.
12. Matsushima-Miyagi T, Hatano K, Nomura M, Li-Wen L, Nishikawa T, Saga K et al. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. Clin Cancer Res 2012; 18: 6271-6283.
13. Zeng J, Fournier P, Schirrmacher V. Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus. Virology 2002; 297: 19-30.
14. Kubota T, Matsuoka M, Xu S, Otsuki N, Takeda M, Kato A et al. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms. J Biol Chem 2011; 286: 8165-8175.
15. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 2001; 20: 240-251.
16. Gong F, Sun L, Wang Z, Shi J, Li W, Wang S et al. The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR. Nucleic Acids Res 2011; 39: 4640-4652.
17. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001; 21: 1249-1259.
18. Brubaker SW, Gauthier AE, Mills EW, Ingolia NT, Kagan JC. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 2014; 156: 800-811.
19. Lei Y, Moore CB, Liesman RM, O'Connor BP, Bergstralh DT, Chen ZJ et al. MAVS-mediated apoptosis and its inhibition by viral proteins. PloS One 2009; 4: e5466.
20. Holm GH, Zurney J, Tumilasci V, Leveille S, Danthi P, Hiscott J et al. Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem 2007; 282: 21953-21961.
21. Huang Y, Liu H, Li S, Tang Y, Wei B, Yu H et al. MAVS-MKK7-JNK2 defines a novel apoptotic signaling pathway during viral infection. PLoS Pathog 2014; 10: e1004020.
22. Guan K, Zheng Z, Song T, He X, Xu C, Zhang Y et al. MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltage-dependent anion channel 1. Mol Cell Biol 2013; 33: 3137-3149.
23. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003; 424: 516-523.
24. Besch R, Poeck H, Hohenauer T, Senft D, Hacker G, Berking C et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 2009; 119: 2399-2411.
25. Li HM, Fujikura D, Harada T, Uehara J, Kawai T, Akira S et al. IPS-1 is crucial for DAP3- mediated anoikis induction by caspase-8 activation. Cell Death Differ 2009; 16: 1615-1621.
26. Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y et al. Oncolytic viruses as therapeutic cancer vaccines. Mol Cancer 2013; 12: 103.
27. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009; 420: 1-16.
28. Elankumaran S, Rockemann D, Samal SK. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 2006; 80: 7522-7534.
29. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176: 4894-4901.
30. Glas M, Coch C, Trageser D, Dassler J, Simon M, Koch P et al. Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. Stem Cells 2013; 31: 1064-1074.
31. Estornes Y, Toscano F, Virard F, Jacquemin G, Pierrot A, Vanbervliet B et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ 2012; 19: 1482-1494.
32. Sun R, Zhang Y, Lv Q, Liu B, Jin M, Zhang W et al. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 2011; 286: 15918-15928.
33. Pothlichet J, Niewold TB, Vitour D, Solhonne B, Crow MK, Si-Tahar M. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol Med 2011; 3: 142-152.
34. Biswas M, Kumar SR, Allen A, Yong W, Nimmanapalli R, Samal SK et al. Cell-type-specific innate immune response to oncolytic Newcastle disease virus. Viral Immunol 2012; 25: 268-276.
35. Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A et al. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 2010; 29: 1762-1773.
36. Kirshner JR, Karpova AY, Kops M, Howley PM. Identification of TRAIL as an interferon regulatory factor 3 transcriptional target. J Virol 2005; 79: 9320-9324.
37. Nakaya T, Sato M, Hata N, Asagiri M, Suemori H, Noguchi S et al. Gene induction pathways mediated by distinct IRFs during viral infection. Biochem Biophys Res Commun 2001; 283: 1150-1156.
38. Kim TK, Lee JS, Jung JE, Oh SY, Kwak S, Jin X et al. Interferon regulatory factor 3 activates p53-dependent cell growth inhibition. Cancer Lett 2006; 242: 215-221.
39. El Maadidi S, Faletti L, Berg B, Wenzl C, Wieland K, Chen ZJ et al. A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bakindependent apoptosis. J Immunol 2014; 192: 1171-1183.
40. Mandriota SJ, Buser R, Lesne L, Stouder C, Favaudon V, Maechler P et al. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells. J Biol Chem 2010; 285: 13092-13106.